Nutrition and Chemotherapy
JEUNETCHIMIO
2 other identifiers
observational
200
1 country
1
Brief Summary
Patients treated for cancer nowadays have many means of information and tend to become more and more involved in their health. The interest of a therapeutic fast with detoxifying or even curative properties, with a specific indication for cancer patients treated by chemotherapy, is nowadays relayed by the media. To date, there are no studies conducted on the scope of this information in cancer patients or on the attitudes of oncologists towards this practice and possible positioning requests from patients. We hypothesize that the choice of this practice and its modalities are rarely discussed with oncologists, although it may have deleterious repercussions on the patient's health. We propose a research based on the principles of sociological intervention. Its objectives are a first review of the issue and the establishment of a joint working group, including patients, carers and researchers, which will propose solutions to improve the patient/carer dialogue on this issue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2019
CompletedFirst Posted
Study publicly available on registry
February 15, 2019
CompletedStudy Start
First participant enrolled
February 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedFebruary 15, 2019
February 1, 2019
10 months
February 11, 2019
February 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients who voluntarily changed their eating habits
Number of patients who voluntarily changed their eating habits will be reported
1 year
Secondary Outcomes (4)
Number of patients on therapeutic fasting or restrictive diet during chemotherapy treatment
1 year
Number of patients using complementary or alternative medicines
1 year
Number of patients discussing these different practices with their oncologist
1 year
Number of patients discussing these different practices with other caregivers
1 year
Study Arms (1)
Patients undergoing chemotherapy treatment
Patients over 18 years of age, followed at the ICLN day hospital or hospitalized and undergoing chemotherapy treatment
Interventions
The questionnaire focuses on the dietary practices of patients treated with chemotherapy. It consists of 35 questions, completing an average of 20 minutes. Interviews will be conducted with patients who have changed their diet since the beginning of their treatment in order to further develop the results of the quantitative survey.
Eligibility Criteria
Patients who intend to practice, or who practice a form of fasting during their chemotherapy treatment will be proposed to participate to a qualitative study to collect more information about their fasting.
You may qualify if:
- Major patients, follow-up on Institut de Cancerology Lucien Neuwirth day service chemotherapy treatment
- Patient affiliated or entitled to a social security scheme
- Patient who received informed information about the study
- Patient able to read French
- Patients participating in the qualitative study:
You may not qualify if:
- Refusal to participate, protected adult person, under guardianship or curatorship
- Person unable to understand the conduct of the study
- Person with a documented history of cognitive or psychiatric disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, 42270, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre Fournel, MD
Institut de Cancérologie Lucien Neuwirth
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2019
First Posted
February 15, 2019
Study Start
February 20, 2019
Primary Completion
December 31, 2019
Study Completion
September 30, 2020
Last Updated
February 15, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share